DOH to probe possible Dengvaxia overpricing

DOH to probe possible Dengvaxia overpricing

The Department of Health (DOH) will look into the reason why the government bought the now-controversial vaccine, Dengvaxia, for P1,000 per dose instead of P600, Health Secretary Francisco III said on Wednesday.

The post DOH to probe possible Dengvaxia overpricing appeared first on Inquirer News.

Read more

Senators seek for answers, solutions amid anti-dengue vaccine mess

As the Senate investigation into the P3.5 billion anti-dengue immunization program started on Monday, lawmakers appealed for answers and solutions in the midst of the vaccine fiasco that might have endangered the lives of more than 800,000 children.

The post Senators seek for answers, solutions amid anti-dengue vaccine mess appeared first on Inquirer News.

Read more

Vaccinated Quezon City cops worried

Some Quezon City policemen and civilian personnel who availed themselves of the free dengue shots in September have expressed concern over their health after the manufacturer, Sanofi Pasteur, said it could lead to more serious diseases.

The post Vaccinated Quezon City cops worried appeared first on Inquirer News.

Read more

Robredo: Probe bungling of vaccine program

Robredo: Probe bungling of vaccine program

Vice President Leni Robredo on Sunday called on the government to look into the effects of a wrongly administered dengue vaccine on the health of hundreds of thousands of schoolchildren in the country and ensure that those who bungled the immunization program would be held liable.

The post Robredo: Probe bungling of vaccine program appeared first on Inquirer News.

Read more

Gov’t suspends use of dengue vaccine

The Department of Health said yesterday that it had suspended use of a landmark vaccine for the potentially deadly dengue virus after its manufacturer warned it could worsen the disease in some cases.

Read more

WHAT WENT BEFORE: Dengue vaccine

WHAT WENT BEFORE: Dengue vaccine

In December 2015, Dengvaxia, the world’s first vaccine against dengue virus developed by French pharmaceutical company Sanofi Pasteur, was licensed and approved for use in the Philippines by the Food and Drug Administration (FDA).

The post WHAT WENT BEFORE: Dengue vaccine appeared first on Inquirer News.

Read more

Citing risks, DOH stops P3.5-B dengue vaccine drive

Citing risks, DOH stops P3.5-B dengue vaccine drive

The Department of Health (DOH) has suspended a massive dengue immunization program and on Friday ordered the close observation of those who had received the world’s first antidengue vaccine after its manufacturer admitted it could worsen the disease in some cases.

The post Citing risks, DOH stops P3.5-B dengue vaccine drive appeared first on Inquirer News.

Read more